Therapeutic pipeline

Acceleratingtoward the clinic.

Our lead AI-designed candidates are now being tested in vivo. Pipeline data and methods are available under NDA on request.

4 programs

generated and validated in 2 months · expanding

program-level data · reveal soon

For investors and partners

Programs

Four AI-designed radiopharmaceutical programs.

One lead candidate per target.

Target ···· nM
Target ···· nM
Target ···· nM
Target ···· nM

Experimental Kd · Targets, affinities and status · reveal soon

Program status

Six stages, first design to first trial.

All programs are preclinical and investigational.

Stage 01··
Stage 02··
Stage 03··
Stage 04··
Stage 05··
Stage 06··

Stage-by-stage status · reveal soon

Therapeutic pipeline

Reveal soon.

Four AI-designed radiopharmaceutical programs are being tested in vivo. Program-level data will be published here.

Request the pipeline data Read the science

Epitorix's pipeline programs are investigational and preclinical. No Epitorix product has been approved by the FDA, the EMA or any other regulator, and no clinical safety or efficacy has been established.

A closed cylindrical metal vial shield with a knurled screw lid and a yellow radiation-warning label, beside one sealed glass vial on a pale laboratory bench. — A single-vial shield, closed, beside a crimp-sealed vial

The models behind the programs

Designed with our own models.

Each candidate was generated, ranked and computationally de-risked in house — by the same models offered through EPiQ™ and PharmPhax™.

See the products

Contact

Ask for the data.

Investors and partners can request the pipeline data and methods under NDA; program-level results are published here at reveal.

Laboratory bench · liquid handler and assay plates